As noted by Hughes et al. [15], dystrophin mutations cause the disruption of sarcolemal stability and cytoskeletal organization, which results in several intracellular stressors contributing to disease progression and cardiomyopathy. The gene discussed is DMD; the disease is cardiomyopathy.